TNFRSF11B and cancer: Cancer cells in the skeleton activate osteoclasts that mediate bone resorption and supplemental release from the bone matrix of growth factors, resulting in tumor proliferation and impaired bone turnover, while osteoblasts in bone metastasis decrease osteoprotegerin production, inducing further osteolysis.